Nishan H. Fernando

Hematology
1505 Northside Blvd
Suite 3100
Cumming, GA 30041

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.

Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.

Journal: Cancer
Published: February 07, 2018
Showing 1-1 of 1

Last Updated: 09/26/2026